These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 11298356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A, Aseffa A, Rachinel N, Breton M, Otten L, Tacchini-Cottier F, Röcken M, Doyen N, Acha-Orbea H, Locksley RM, MacDonald HR, Launois P, Louis J.
    Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
    [Abstract] [Full Text] [Related]

  • 3. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
    Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Louis JA, Launois P.
    J Immunol; 1998 Dec 01; 161(11):6156-63. PubMed ID: 9834101
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
    Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, Seegmüller I, Voigt H, Launois P, Levine AD, Wagner H, Heeg K, Louis JA, Röcken M.
    Nat Immunol; 2001 Nov 01; 2(11):1054-60. PubMed ID: 11600887
    [Abstract] [Full Text] [Related]

  • 6. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
    von der Weid T, Beebe AM, Roopenian DC, Coffman RL.
    J Immunol; 1996 Nov 15; 157(10):4421-7. PubMed ID: 8906817
    [Abstract] [Full Text] [Related]

  • 7. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG.
    J Immunol; 1998 Dec 01; 161(11):6171-9. PubMed ID: 9834103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S, Coffman RL.
    J Immunol; 1995 Apr 15; 154(8):3779-87. PubMed ID: 7706719
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S, Coffman RL.
    J Immunol; 1997 Feb 15; 158(4):1559-64. PubMed ID: 9029090
    [Abstract] [Full Text] [Related]

  • 12. Some of the early events underlying Th2 cell maturation and susceptibility to Leishmania major infection in BALB/c mice.
    Himmelrich H, Launois P, Tacchini-Cottier F, Louis JA.
    Biol Chem; 1999 Feb 15; 380(7-8):909-14. PubMed ID: 10494841
    [Abstract] [Full Text] [Related]

  • 13. Blockade of CD86 in BALB/c mice infected with Leishmania major does not prevent the expansion of low avidity T cells.
    Moro M, Filippi C, Gallard A, Malherbe L, Foucras G, Akiba H, Yagita H, Guéry JC, Glaichenhaus N.
    Eur J Immunol; 2002 Dec 15; 32(12):3566-75. PubMed ID: 12516542
    [Abstract] [Full Text] [Related]

  • 14. Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response.
    Hondowicz BD, Scharton-Kersten TM, Jones DE, Scott P.
    J Immunol; 1997 Nov 15; 159(10):5024-31. PubMed ID: 9366430
    [Abstract] [Full Text] [Related]

  • 15. Early IL-4 production does not predict susceptibility to Leishmania major.
    Scott P, Eaton A, Gause WC, di Zhou X, Hondowicz B.
    Exp Parasitol; 1996 Nov 15; 84(2):178-87. PubMed ID: 8932767
    [Abstract] [Full Text] [Related]

  • 16. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
    Noben-Trauth N, Paul WE, Sacks DL.
    J Immunol; 1999 May 15; 162(10):6132-40. PubMed ID: 10229856
    [Abstract] [Full Text] [Related]

  • 17. In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-.
    Launois P, Ohteki T, Swihart K, MacDonald HR, Louis JA.
    Eur J Immunol; 1995 Dec 15; 25(12):3298-307. PubMed ID: 8566015
    [Abstract] [Full Text] [Related]

  • 18. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions.
    Launois P, Gumy A, Himmelrich H, Locksley RM, Röcken M, Louis JA.
    J Immunol; 2002 May 01; 168(9):4628-35. PubMed ID: 11971011
    [Abstract] [Full Text] [Related]

  • 19. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA, Glaichenhaus N, Laman JD, Carlier Y.
    Infect Immun; 2001 Jan 01; 69(1):617-21. PubMed ID: 11119565
    [Abstract] [Full Text] [Related]

  • 20. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
    Morris L, Troutt AB, Handman E, Kelso A.
    J Immunol; 1992 Oct 15; 149(8):2715-21. PubMed ID: 1357029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.